Metraipolis › archive › dc_efd41436d3d7

Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases — Europe PMC PMID:42405136

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42405136
DOI
10.1039/d6ra03396b
License (as archived)
solo-consultazione
Archived
2026-10-18T11:46:34.356Z
SHA-256 of the archived text
d75b5ffcd722c4cf4f215ba6a4e4659a2bc64c41d8591cbc4d43c24389a70deb
Stable URL of this page
https://metraipolis.com/documento/dc_efd41436d3d7

How to cite

Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases — Europe PMC PMID:42405136 — Europe PMC (en), https://europepmc.org/article/MED/42405136 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efd41436d3d7 (Metraipolis archive dc_efd41436d3d7, sha256 d75b5ffcd722c4cf4f215ba6a4e4659a2bc64c41d8591cbc4d43c24389a70deb)
BibTeX
@misc{dcefd41436d3d7,
  title = {Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases — Europe PMC PMID:42405136},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42405136},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efd41436d3d7; sha256 d75b5ffcd722c4cf4f215ba6a4e4659a2bc64c41d8591cbc4d43c24389a70deb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42405136. Agents can read the archived copy with the MCP tool read_document.